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FACULTY SENATE
April 6, 2009
3:00 – 4:30 p.m.
Merrill-Cazier Library Room 154

Agenda

3:00

Call to Order
Approval of minutes March 2, 2009………………………………………………………….Mike Parent

3:05

Announcements………………………………………………………………………………Mike Parent
• Roll Call
• Next year’s Faculty Senate Calendar
• Senate and Senate Committee Elections

3:10

University Business…………………………………………………………..Stan Albrecht, President
Raymond Coward, Provost

3:30

Consent Agenda
• PRPC Annual Report……………………………………………………………..........Scott Cannon
• Policy Changes associated with USU’s Human Research Protection Program…….Russ Price
• EPC Items………………………………………………………………………………….Larry Smith

3:40

Information Items
• Honorary Degrees and Awards………………………………………………Sydney Peterson
• Commencement………………………………………………………………..Sydney Peterson

4:00

New Business
Nominations for Faculty Senate President Elect………………………………………….Mike Parent

4:20

Adjournment………………………………………………………………………………....Mike Parent

USU FACULTY SENATE
MINUTES
MARCH 2, 2009
Merrill-Cazier Library, Room 154

Mike Parent called the meeting to order at 3:00 p.m.
Approval of Minutes
John Kras moved to approve the minutes of February 2, 2009. Byron Burnham seconded, motion
carried.
Announcements
1. Roll Call. Senators are reminded to sign the roll at each meeting.
2. Time Table for Electing Senate President. By code the President-Elect is elected from the floor
at the April Senate meeting by ballot and reported to the senate by the May meeting. The May
meeting is really held at the end of April. We will entertain nominations from the floor at the next
Faculty Senate meeting. There are some restrictions as to who is eligible. A nominee should
have completed one year on the senate, those who are in their final term of their commitment are
not eligible.
3. Committee Elections. The Committee on Committees is responsible for informing college deans
and their administrative assistants about the election for various committees and also members to
the Faculty Senate. Elections should be held during the month of March and results presented to
the Senate in April. Refer to section 402.10.2 of the code if you have any questions.
University Business - President Albrecht
The final 2009 FY budget came in at another $171 million below appropriations. The legislature
decided to cover the shortfall using one time monies. For the university it means a 4% reduction
taken last September, plus the January 7.3% reduction with 3.625% backfill. Moving forward there is
an 11.3% ongoing reduction for the FY 2010 already in place with a possibility of additional cuts up to
17.5%. There may be money coming to the university from the economic stimulus package and a
combination of other sources. Notice has been sent out to the Deans about how the major federal
agencies have received additional funding as part of the stimulus package. President Albrecht urges
Deans and all departments to utilize these increased opportunities.
There are two other important bills the legislature is considering that will impact Utah State University.
First, House Bill 364 includes additional boarder waivers for student recruiting and also a legacy
component which would allow children of USU alumni to attend USU at in state tuition rates. This bill
passed the House unanimously but still must pass the Senate.
Secondly, House Bill 432 gives temporary authority to College and University Presidents to shift funds
between line items in addressing the budget reductions. This would give us a little more flexibility in
addressing budget issues.
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President Albrecht met with several alumni and donors in Palm Springs recently. The common theme
among the donors is that they love Utah State and want to continue funding their scholarships and
programs but given the economy it will be more difficult to meet their commitments to us.
Provost Coward updated the Senate on the Vice President of Student Services search. The search
committee has made a recommendation to bring in 4 candidates and the president has approved
them. They will begin their campus visits after spring break.
Consent Agenda Items
John Kras moved to approve the Consent Agenda, Vince Wickwar second, and the motion
carried.
Information Items
ASUSU Tobacco Policy. Jeremy Jennings presented the proposed tobacco policy. Last year
the students supported a total ban of tobacco use on campus. The total ban was rejected by the
administration and they requested the policy be revised. The current proposal includes an
expansion of the clean air act, the 25 foot barrier to include “in courtyards or other areas where
air circulation may be impeded by architectural landscaping or barriers, such as but not limited to
the TSC patio and bus stop enclosures”. Also addressed is the sale of tobacco on campus and
also group gatherings and tobacco advertising.
The proposal has been presented to CEA and PEA. The question was raised how selling
tobacco on campus harms non-smokers. Jeremy said that the smokers he spoke with were not
concerned about this. It is available elsewhere at more reasonable prices and they do not need it
sold on campus.
Concerns were raised about international students and cultural differences with smoking. Also
discussed were questions if smoking on the patio infringes on nonsmokers rights. Lengthy
discussion continued on issues surrounding the proposed tobacco policy.
Mike Parent clarified that the Senate has an opportunity to provide feedback on this issue, but it is
not a part of code that the Senate has the authority to change. Provost Coward confirmed that
this is an administrative decision. A vote would be welcome to obtain a sense of the faculty but
would not be binding in policy.
A motion was made and seconded that a straw poll be taken on the proposed revision to show a
sense of the Senate for support of the proposal. Votes were made by show of hands and
counted with 21 in favor of supporting the motion and 24 opposing. Motion failed.
ASUSU Excused Absence Policy. Jeremy Jennings presented the proposed changes to the
Excused Absence Policy, adding a provision for students who are interviewing for professional
school, graduate school or internships and the second modification addresses the University
Ambassador program.
John Kras moved to accept the proposal as a package; it was seconded by Nat Frazier. Motion
carried.
Key Issues and Action Items
PRPC Grievance Policies and Procedures 407.1.2. Scott Canon presented the second
reading of the revision to section 407.1.2. The current revision includes language that the
calendar may be suspended by the chair. At the last FSEC meeting Provost Coward pointed out
possible inconsistencies with this language and PRPC was asked to review this and make
suggestions to clarify the issue. PRPC suggests that the statement “suspension of the calendar
by the chair” be stricken and limit this specifically to sections 407.4 and 407.6 and specify that
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any suspension of the calendar is by majority vote of the Academic Freedom and Tenure
Committee.
A substitute motion was made by Pat Lambert to modify the amendment to read the calendar
may be suspended by a majority vote of the panel appointed by the AFT Committee. Several
seconds were received and the motion carried. This passes as a second reading.
A motion was made and seconded for PRPC to look at the level 2 changes of section 406 of the
code. Motion carried.
Adjournment
The meeting adjourned at 4:01 p.m.
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PRPC Annual Report to the Faculty Senate Executive Committee

Scott Cannon, chair

Committee Members

15‐Mar‐09

CHARGE: The Professional
Responsibilities and Procedures
Committee advises the Faculty Senate
regarding revision and implementation of
policy, and the composition and revision
of the Faculty Handbook.

Scott Cannon (10) Chair, Science

Meetings

David Hole (09) Agriculture
David Paper (10) Business
Susan Turner (10) Ed & Human Services
John Engler (10) HASS
Robert Schmidt (09) Natural Resources
Bob Parson (11) Libraries
Margie Memmott (11) Extension

12‐Mar‐08
9‐Apr‐08
10‐Sep‐08
8‐Oct‐08
12‐Nov‐08
10‐Dec‐08
14‐Jan‐09
11‐Feb‐09

Brett Shelton (09) Senate
James Evans (09) Senate
Paul Wheeler (09) Engineering

Completed Actions

Code section

407.1.2, 407.6, version G

date
Mar, 2009

disposition
passed by Senate

Simplification of the Academic Due Process calendar and clarification of the calendar suspension policy

202

Feb, 2009

passed by Senate

Review and editing of suggested policy changes proposed by the Ad‐Hoc Code Review Committee

402.11.1, 402,12.6

Dec, 2009

passed by Senate

Sep, 2008

passed by Senate

Discontinuation of the Distance and Electronic Education Subcommittee

405.7.2, version B

Tenure Process: The inclusion of a list of potential reviewers that a candidate does not want contacted.

403.3.3, 407.6.2

Sep, 2008

passed by Senate

LGBT Inclusive Policy Change (FDDE Committee): PRPC was charged to draft language, as proposed by the FDDE

407.6.2

Sep, 2008

passed by Senate

Scheduling Grievances and Sanctions. Modification of grievance and sanction timelines.

Actions under consideration

406

Review and editing of suggested policy changes proposed by the Ad‐Hoc Code Review Committee

Under PRPC
consideration

20 February 2009

ITEM FOR ACTION

RE:

Amendment of USU Policy #307, “Conflicts of Interest”

Concomitant with the efforts to accredit USU’s Human Research Protection Program
(HRPP), the USU Office of Compliance Assistance requests an administrative amendment of the
existing Conflicts of Interest Policy to meet specific requirements of the accrediting body.

EXECUTIVE SUMMARY
One of the standards for accreditation of the HRPP, established by the Association for the
Accreditation of Human Research Protection Programs (AAHRPP), requires that:
“The Organization has and follows written policies and procedures to identify, manage,
and minimize individual conflicts of interest of investigators. The Organization works
with the IRB regarding conflicts of interest, when appropriate.” (emphasis added).
Based on this standard, AAHRPP has recommended additional language be added to the
procedures section of the existing policy as follows:
“When a disclosed conflict of interest involves human research, the Conflict of Interest
Committee shall review the conflict prior to USU’s Institutional Review Board (IRB)
review, and provide a timely report to the IRB indicating the Committee’s action
concerning the conflict and its management. The IRB shall have final authority to decide
whether the conflicting interests and their proposed management will allow the human
research to be approved.”
This language is in keeping with USU’s intent to coordinate COI administration with HRPP
activities, and places no additional burden on the research community.

RECOMMENDATION
The President and Vice President for Research recommend that the Board of Trustees approve
the requested administrative change to USU Policy #307, “Conflicts of Interest.”

RESOLUTION
UTAH STATE UNIVERSITY
BOARD OF TRUSTEES
WHEREAS, Utah State University has applied for accreditation of its Human Research Protection
Program by the Association for the Accreditation of Human Research Protection Programs
(hereinafter, AAHRPP); and
WHEREAS, AAHRPP requires that “the Organization works with the IRB regarding conflicts of
interest, when appropriate,” and has suggested specific appropriate language modifications to
the existing USU Policy #307, “Conflicts of Interest;” that will ensure appropriate coordination;
and
WHEREAS, it is USU’s intent to strengthen its policies and procedures in managing conflicts of
interest and also in protecting human participants in USU research:
NOW, THEREFORE, BE IT RESOLVED, that the Utah State University Board of Trustees hereby
approves the proposal from the Office of Compliance Assistance to amend Policy #307,
“Conflicts of Interest,” as presented.

POLICY MANUAL
GENERAL

Number 307
Subject: Conflicts of Interest
Date of Origin: January 24, 1997
Effective Date of Last Revision: January 24, 2003

307.1 INTRODUCTION AND DEFINITIONS
For the purposes of this policy, a conflict of interest exists when a University employee
owes a professional obligation to the University, which is or can be compromised by the
pursuit of outside interests. Types of conflicts of interest that may exist include:
•
•
•

Financial conflict - for example, an employee has a financial interest in a
company that is funding research in his/her lab.
Conflict of commitment - for example, an employee has committed more than
100% effort to a range of projects.
Conflict of allegiance - for example, an employee's personal interests may create a
bias in his/her discharge of University duties.

The purposes of this policy are to:
(1) Enhance the integrity of institutional research;
(2) Enhance the quality of the institution's educational program;
(3) Enhance the viability of the institution's outreach mission, especially as it relates to
information diffusion and technology development and commercialization;
(4) Prevent a conflict of interest from harming the University and/or the employee.

307.2 POLICY
University employees shall not realize personal gain in any form which improperly
influences the conduct of their University duties. They shall not knowingly use
University property, funds, position, or power for personal or political gain, nor engage in
any financial or personal activity which may disadvantage the University. They shall
report in writing all reasonably foreseeable conflicts.
This policy does not intend to deny any employee opportunities available to all other
citizens of the state to acquire private economic or other interests so long as this does not
interfere with the full and faithful discharge of his/her University duties or disadvantage
the University in any manner. Conflicts of interest are not necessarily unwarranted,
unethical or illegal, nor are they always avoidable. Rather, it is the failure to disclose
conflicts or potential conflicts to appropriate authorities; to comply with approved
conflict management plans; to continue to engage in a conflict after disapproval by
appropriate authorities; or to further conduct oneself in a manner that unethically hurts,
hinders, or disadvantages the University that must be avoided. Potential conflicts of
interest must be disclosed and managed as per policy.
References:
•
•

•
•
•

Utah Code 67-16-1 et. seq. ,"Utah Public Officers and Employees' Ethics Act"
Title 42 of the Code of Federal Regulations, Part 50.601 et.seq., "Subpart F-Responsibility of Applicants for Promoting Objectivity in Research for Which
PHS Funding Is Sought." http://ori.dhhs.gov/html/policies/fedreg42cfr50.asp
National Science Foundation Grant Policy Manual (95-26) Section 510, "Conflict
of Interest Policies" http://www.nsf.gov/pubs/2002/nsf02151/gpm02_151.pdf
USU Policy 403.3.3(2) Academic Freedom and Professional Responsibility,
Standards of Conduct
USU Policy 327 Intellectual Property and Creative Works

307.3 PROCEDURES
3.1 Internal Disclosure of Conflicts of Interest
All conflicts of interest shall be disclosed to an employee's line supervisor through:
(1) Annually disclosing that an employee does or does not have a conflict of interest.
(2) Event-driven disclosures made upon proposing or conducting work that will create a
conflict of interest, disclosing the nature of the conflict and the expected duration of the
conflict.3.2 Managing Conflicts of Interest
Every conflict of interest shall be appropriately managed by the University according to a
conflict management plan to be prepared by the employee and the employee's immediate

supervisor, and/or a University compliance officer if available, and approved by the
immediate supervisor (if not involved in preparation of the management plan), the dean
or vice president (as appropriate), the Conflicts of Interest Committee, and the Provost or
an authorized designee of the Provost. Management plans shall be appropriate to the
conflict of interest, and may employ management approaches including the following:
(1) Avoidance.
(2) Public Disclosure. This approach should be used, for example, where human subjects
will be involved in research conducted by an investigator who has a financial interest in
the company sponsoring the research (or licensing a technology in which the investigator
has a financial interest). In such cases, the informed consent form (as administered
through the Institutional Review Board) shall disclose the financial interest to the
participants, and any publication of study results shall disclose such financial interest.
(3) Balance. Diverse interest groups (including non-University third parties) are included
in oversight of the project.
(4) Mediation. Such mediation may include oversight by the immediate supervisor, the
dean or vice president (as appropriate), or a committee appointed by the immediate
supervisor. In no case shall an investigator have direct financial oversight of a project
sponsored by an organization in which he/she has a financial interest, nor shall any
employee under the direct control of the investigator have financial oversight.
(5) Abstention. The investigator does not participate in the project as a University
employee, but acts only in his/her role in the sponsoring organization.
(6) Divestiture. The employee removes the conflict by forfeiting his/her interest in the
sponsoring organization/licensee. In such cases, the employee permanently or for a
specified period of time shall not resume a financial interest in the sponsoring
organization or receive other forms of compensation from the company.
(7) Prohibition. The employee permanently withdraws from the secondary interests.
(8) No action required.

3.3 University Oversight of Conflicts of Interest
A Conflicts of Interest Committee shall be appointed by the University President to
oversee the implementation of this policy. The Committee shall consist of the Provost or
an authorized designee of the Provost (Committee Chair); representatives from the Office
of the Vice President for Research, the Institutional Review Board, the Faculty Senate,
the Office of Technology Management and Commercialization; a member external to the
University; and any others deemed appropriate. The University compliance officer shall

serve as an ex-officio member of the Committee. The Committee shall meet on a regular
basis to review all disclosed conflicts of interest, shall review for approval all conflict of
interest management plans, and shall monitor all active plans on a regular basis.
When a disclosed conflict of interest involves human research, the Conflict of Interest
Committee shall review the conflict prior to USU’s Institutional Review Board (IRB)
review, and provide a timely report to the IRB, indicating the Committee’s action
concerning the conflict and its management. The IRB shall have final authority to decide
whether the conflicting interests and their proposed management will allow the human
research to be approved.

20 February 2009
ITEM FOR ACTION
RE:

Amendment of USU Policy #308, “Human Participant in Research”
Concomitant with the efforts to accredit USU’s Human Research Protection Program
(HRPP), the USU Office of Compliance Assistance requests administrative amendments
of the existing Human Participants in Research Policy to meet specific requirements of
the accrediting body.

EXECUTIVE SUMMARY
Standards for accreditation of the HRPP, established by the Association for the Accreditation of
Human Research Protection Programs (AAHRPP), and interaction with AAHRPP personnel have
identified administrative changes within nine sections to strengthen USU’s primary policy
guiding research with human participants. Among these, administrative changes to the
following sections are recommended, (as included in Attachment A):
•
•
•
•
•
•

Section 3 (line 31), indicating that no official of the university can approve research that
has been prohibited by the IRB;
Section 4.3(3), specifying in more detail informed consent requirements imposed by
existing regulations;
Section 4.5, specifying additional records to be retained by the IRB;
Section 4.8, providing guidance on steps to be taken when evaluating allegations of non‐
compliance;
Section 4.11, providing additional guidance on reporting of unanticipated problems
Section 6, adding specific prohibitions on certain recruiting practices.

All proposed changes are consistent with current USU practice, and will more effectively
communicate USU’s expectations with regard to human research protection procedures at
USU.

RECOMMENDATION
The President and Vice President for Research recommend that the Board of Trustees approve
the requested administrative change to USU Policy #308, “Human Participants in Research.”

RESOLUTION
UTAH STATE UNIVERSITY
BOARD OF TRUSTEES
WHEREAS, Utah State University has applied for accreditation of its Human Research Protection
Program by the Association for the Accreditation of Human Research Protection Programs
(hereinafter, AAHRPP); and
WHEREAS, AAHRPP has suggested specific appropriate language modifications to the existing
USU Policy #308, “Human Participants in Research;” that more clearly delineate USU
expectations with regard to some aspects of the conduct of human research; and
WHEREAS, it is USU’s intent to strengthen its policies and procedures in protecting human
participants in USU research:
NOW, THEREFORE, BE IT RESOLVED, that the Utah State University Board of Trustees hereby
approves the proposal from the Office of Compliance Assistance to amend Policy #308, “Human
Participants in Research,” as presented.

ATTACHMENT A
LISTING OF SPECIFIC MODIFICATIONS TO POLICY #308, “HUMAN PARTICIPANTS IN
RESEARCH”
Key:
Normal text:
Strikethrough text:
Highlighted text:

Indicates existing language to be retained
Indicates language to be removed
Indicates language to be added

SECTION 2
…The requirement for IRB review and approval applies to all Human Research involving USU
Investigators or Human Participants in all locations, whether funded or not, and whether conducted by
faculty, students or other employees... No such study shall begin before it has been approved by the
IRB. No other official of the university may approve human research that has not been approved by the
IRB.
SECTION 3.1
Principles that IRB members consider during their reviews are set forth in the IRB Protocol Review
Standards document (available at: http://www.usu.edu/research/irb/forms/IRB%20Protocol
%20Review% 20Standards%203‐19‐03.pdf) Review Checklist document (available at:
http://irb.usu.edu/htm/guidelines) current at the time of application.
SECTION 3.2.2
If the IRB administrator finds that a protocol involves no more than Minimal Risk, expedited review may
be conducted by the IRB administrator and a limited number of experienced board members with who
possess expertise in the Research activity being conducted.
SECTION 3.3.3
Informed Consent Form – This document must conform to the requirements of the IRB Standard
operating Procedures…and be approved for use in the study by the IRB. It contains the following
elements as required under 45 CFR 46.116: …
A description of reasonably foreseeable risks or discomforts
A description of reasonably foreseeable benefits to participants and others …
…Contact information for:
Answers to pertinent questions about the research
Answers to pertinent questions about the research participants’ rights
Reporting of research related injuries or harms

The research team (if not provided above) for questions concerns or complaints
Someone independent of the research team for problems, concerns, questions, information or
input.
A statement explaining that participation is voluntary and that there is no penalty for withdrawal or loss
of benefit to which the participant was entitled if the participant withdraws or refuses to participate.
When appropriate:
The consequences of a participant’s decision to withdraw from the research
An approximate number of participants involved in the study.
SECTION 3.6.2
The IRB shall retain for at least three years (or for protocols which are cancelled without participant
enrollment, for at least a three‐year period after cancellation) the following records in accordance with
45 CFR 45 Section 115:
Minutes of IRB meetings
Protocols
Scientific evaluations
DHHS‐approved sample consent documents and protocols, when they exist.
Reports of injuries to participants
Records of continuing review activities, including Continuing Review Status Reports submitted to
the investigator
Other progress reports submitted by investigators
Statements of significant new findings provided to participants
For initial and continuing review of research by expedited procedure:
The specific permissible category
A description of action taken by the reviewer
Any findings required under regulations
For exemption determinations, the specific category of exemption

Unless documented in the IRB minutes, determinations required by the regulations and
protocol‐specific findings supporting those determinations for:
Waiver or alteration of the consent process
Research involving pregnant women, fetuses and neonates
Research involving prisoners
Research involving children
For each protocol’s initial and continuing review, the frequency for the next continuing review.
Copies of all correspondence between the IRB and Investigators
A list of IRB members (to be maintained continuously)
The Standard Operating Procedures of the IRB (to be maintained continuously)
SECTION 3.9

Allegations and findings of non‐compliance. Non‐compliance, for the purposes of this policy, shall be
the failure to follow the regulations or the requirements and determinations of the IRB. Incidents of
non‐compliance shall be handled by the IRB unless the nature or duration of non‐compliance indicates
the need for institutional intervention.
Non‐compliant activities may be identified through IRB oversight, self‐reporting, or reporting
from employees, Human Participants or others. Allegations of non‐compliance may be
presented to the IRB administrator, the Federal Compliance Manager at the OCA, USU’s Internal
Audit Services (IAS) either through the hotline or with a representative of IAS, or to University
Counsel. Reports of allegations should be made to the chair of the IRB, and any report of non‐
compliant behavior involving Research under the oversight of the IRB shall be reported to the
IRB chair at the earliest opportunity….
The IRB Chair shall determine whether non‐compliance is serious or continuing. Upon making a
finding of non‐compliance that is neither serious nor continuing, the IRB Chair shall take steps to
correct the non‐compliant behavior with the investigator….
…In conjunction with USU’s Responsible Institutional Official (RIO) and others, the OCA receives
and processes allegations of misconduct and non‐compliance arising from Research activities of
the university, and facilitates any associated inquiries and investigations. Information about and
contacts for the OCA are available at: http://www.usu.edu/aia/academic/c_overview.cfm.
Following investigation by the OCA, serious or continuing non‐compliance is reviewed by the
convened IRB. The Federal Compliance Manager, an ex officio member of the IRB, presents the
findings if the investigation. All members of the IRB receive a copy of the initial application, the
protocol, information describing the non‐compliance, and the results of the OCA investigation.
The IRB may consider actions including

Suspension of the research
Termination of the research, and
Notification of current participants when such information may relate to a participant’s
willingness to continue to take part on the research
Increasing frequency of continuing review.
SECTION 3.10
Adverse events and u Unanticipated problems. Investigators shall follow the procedures contained in
the IRB Standard Operating Procedures, Chapter 9.j and IRB Handbook whenever an adverse event or
another unanticipated problem arises having to do with risks to Human Participants or others. The P.I.
shall have responsibility for identifying and reporting unanticipated risks as set forth in SOPs, Chapter
4.f, submitting information to the chair of the IRB in sufficient detail for the chair to draft the report as
required in 3.12, below, and otherwise as required by the SOPs. If the adverse event or unanticipated
risk is life‐threatening, emergency services shall be summoned and all reasonable steps shall be taken to
ensure the safety and well‐being of the Participants or any others affected. …
SECTION 3.12
Reports of unanticipated problems involving risks to participants or others, terminations, suspensions
and serious or continuing non‐compliance shall be submitted to federal agencies in compliance with
applicable regulations. The IO shall ensure that all required reporting is completed within 15 business
days….
The cIRB Chair shall submit the draft report in a timely manner to the OCA and the RIO for
review. The RIO shall have responsibility for final approval and signature of the report, and for
its submission to the appropriate agency. Copies of the reports shall be distributed to the IRB,
OHRP when the research is covered by DHHS regulations, and other federal agencies when
research is overseen by those agencies and such agencies require reporting separate from that
to OHRP….
SECTION 3.14 (New Section)
Recruitment prohibitions. The following activities shall not be permitted:
Payments to professionals in exchange for referrals of potential participants (“finder’s fees”),
Payments designed to accelerate recruitment that are tied to the rate of timing of enrollment
(bonus payments).

POLICY MANUAL
PERSONNEL POLICIES

Number 308
Subject: Human Participants in Research
Effective Date: June 1, 2007

308.1 PURPOSE
The purpose of this policy is to govern the involvement of human participants in the
conduct of research at Utah State University. The University is committed to
safeguarding the rights and welfare of human participants, and complies with the
regulations of the U.S. federal government and the State of Utah.
308.2 DEFINITIONS
2.1 Research
For the purposes of this policy, research is defined in harmony with 45 Code of Federal
Regulations (CFR) 46 as a systematic investigation, including research development,
testing and evaluation designed to develop or contribute to generalizable knowledge.
For the purpose of this policy, generalizable knowledge is any result of research that is
intended to be extended (or generalized) beyond the population or program being
investigated. Such extension shall include public disclosure of such results either in
public settings, through publication of a thesis or dissertation, or through other
dissemination or publication.
The USU Institutional Review Board (IRB) shall have the sole responsibility, through
interaction with the Principal Investigator (PI) and review as set forth in this policy, to
determine whether an investigation to be conducted constitutes research in accordance
with 45 CFR 46, as illustrated in Decision Chart #1, published as guidance by the Office
of Human Research Protections (OHRP), available at:
http://www.hhs.gov/ohrp/humansubjects/guidance/decisioncharts.htm.

2.2 Human Participant
A human participant (“participant”) in research is a living individual, about whom an
investigator (whether professional or student) conducting research obtains:
(1)
(2)

Data through intervention or interaction with the individual; or
Identifiable private information.

The terms “human participant” and “participant” are equivalent to the terms “human
subject” and “subject” as used in the “Common Rule,” 45 CFR 46.
2.3 Human Research
Human research, or research involving human participants, is any research, as defined
above, that involves human participants in accordance with 45 CFR 46 and as illustrated
in Decision Chart #1, published as guidance by the OHRP, available at:
http://www.hhs.gov/ohrp/humansubjects/guidance/decisioncharts.htm.
The USU IRB shall have the sole responsibility of determining whether an investigation
constitutes human research, under the above definition. The following activities, which
may be found to be exempt from Common Rule (45 CFR 46) requirements, shall
nonetheless be included among those to be submitted for IRB review: quality
improvement programs and program evaluations carried out for other than exclusive use
by the organization sponsoring the evaluation, classroom exercises that are associated
with research methodologies courses, public health activities, and innovative health care.
2.4 Investigator
Investigator is a person or entity affiliated with USU, whether as an employee, student or
otherwise, whose role statement, job description, employment assignment, and/or
function within the University is, either in whole or in part, to carry out research. Such
investigators shall include, but not be limited to, USU faculty, professional researchers,
research assistants, laboratory and clinical staff, and others as may be designated by the
Vice President for Research.
Principal Investigator (PI) is an investigator who is an employee of the University and is
authorized by his/her unit and college, or by the Vice President for Research, to take
responsibility for research involving human participants. This individual shall have
primary responsibility for submitting research protocols and carrying out research
programs that protect the health and well-being of Human Participants, as set forth in this
policy.
2.5 Intervention

Intervention includes both physical procedures, by which data are gathered (for example,
venipuncture), and manipulations of the participant or the participant’s environment that
are performed for research purposes.
2.6 Interaction
Interaction includes communication or interpersonal contact between investigator and
participant.
2.7 Vulnerable Populations
The IRB gives special consideration to protecting the welfare of particularly vulnerable
populations, such as children, prisoners, pregnant women, mentally disabled persons, or
economically or educationally disadvantaged persons.
(1)
A child is a person under the age of 18 who is not able to legally consent to
treatments or procedures involved in the research (see Utah Code Annotated 75-1-201
[29]).
(2)
A child’s guardian, according to DHHS regulations, is an individual authorized to
consent on behalf of the child to general medical care.
(3)
A guardian of an incapacitated adult shall be a person who has qualified as such
pursuant to testamentary or court appointment.
2.8 Private Information
Private information includes information about behavior that occurs in a context in which
an individual can reasonably expect that no observation or recording is taking place, and
information which has been provided for specific purposes by an individual and which
the individual can reasonably expect will not be made public (e.g., a medical record).
Private information must be individually identifiable (i.e., the identity of the subject is or
may be ascertained by the investigator or associated with the information) in order for the
obtaining of the information to qualify as research involving human participants.
2.9 Minimal Risk
Minimal risk means that the probability and magnitude of harm or discomfort anticipated
in the research are not greater, in and of themselves, than those ordinarily encountered in
daily life, or during the performance of routine physical or psychological examinations or
tests.
2.10 Conflict of Interest
Conflict of interest is a situation in which a University employee owes a professional
obligation to the University, which is or can be compromised by the pursuit of outside
interests. Conflicts of interest are further defined and discussed in USU Policy 307
Conflicts of Interest.

2.11 Confidentiality
Confidentiality is the withholding of certain information as specified under an agreement
between USU and another individual or entity (e.g., a collaborating institution) wherein
the entities agree to maintain as confidential all private information regarding the
research, protocol, investigational process, and information discovered during the
investigation. Also, the right of a human participant to have private information protected
from disclosure except as allowed under the Privacy Rule (42 CFR 160, 164).
308.3 POLICY
USU investigators must adhere to strict ethical standards when involving human
participants in their research. These standards are in place to protect the basic rights of
participants. Any research that departs from the spirit of these standards violates
University policy. All research performed under the auspices of USU, including
collaborative research conducted with one or more public or private entities, in which
human participants are involved must be reviewed and approved by the Institutional
Review Board (IRB) appointed by the Vice President for Research, or by such other
review body as shall be designated by the IRB. USU, through its Human Research
Protection Program, its IRB and other review processes, works together with
investigators, sponsors and research participants to uphold ethical standards and practices
in its research.
The IRB review and approval process shall be conducted in accordance with all U.S.
federal government and state laws, and all University policies and regulations that govern
the use of human participants in research, including the IRB Handbook and the IRB
Standard Operating Procedures current at the time of the review. The requirement for
IRB review and approval applies to all human research involving USU Investigators or
human participants in all locations, whether funded or not, and whether conducted by
faculty, students, or other employees. It also applies to persons unaffiliated with the
University who wish to investigate participants who are under the protection of the
University, such as students and patients. No such study shall begin before it has been
approved by the IRB. No other official of the University may approve human research
that has not been approved by the IRB. Investigators are encouraged to consult with the
IRB Administrator, or the IRB Chair, during preparation of an early draft of proposals to
be submitted, at which time concise and current details concerning human research can
be obtained.
The IRB web site, at http://www.usu.edu/research/irb , is made available to principal
investigators, investigators, human participants and others in order to provide ready
access to USU’s Policies, Standard Operating Procedures, the IRB Handbook, and
associated information. Interested parties should make use of the information provided
electronically, and whenever appropriate they may contact the IRB Administrator or
Chair for additional assistance with the preparation, approval, and execution of protocols
involving human participants.

Investigators are referred to the following documents and regulations, hereby made a part
of this policy by reference:
(1)
Ethical Principles and Guidelines for the Protection of Human Subjects of
Research (The Belmont Report)
(2)
45 CFR 46 “Protection of Human Subjects,” (The “Common Rule”)
(3)
45 CFR 160 and 164A,E “Standards for Privacy of Individually Identifiable
Health Information,” (“The Privacy Rule”)
(4)
42 CFR 50, Subpart F, “Responsibility of Applicants for Promoting Objectivity in
Research for which PHS Funding is Sought”
(5)
Department of Health and Human Services guide document: “Financial
Relationships and Interests in Research Involving Human Subjects: Guidance for Human
Subjects Protection.”
If an investigator is unsure of the interpretation of the federal and state statutes and
guidelines as listed, or has other questions regarding the applicability or effect of federal,
state, or local laws or regulations, he/she shall contact University Counsel for advice and
direction.
The USU IRB is authorized to approve research protocols involving human participants
through the Federal-Wide Assurance # 00003308, dated September 6, 2002. This
assurance is on file with the Office of Human Research Protections, U.S. Department of
Health and Human Services. USU delegates to the IRB the responsibility for reviewing
research protocols primarily for the purpose of ensuring that human research is carried
out in accordance with ethical principles, as outlined in the Belmont Report, and for
protecting the welfare and rights of human participants. The IRB shall act independently
in this capacity, but shall coordinate its review with other review bodies – including the
Sponsored Programs Office, the Conflicts of Interest Committee, The Office of
Compliance Assistance, and the Office of the Vice President for Research – whose
responsibilities under USU policy include review of the scientific and scholarly validity
of the proposed research study, and its freedom from bias introduced because of
unmanaged conflicts of interest. The IRB is authorized to:
(1)
Approve, require modification to secure approval, or disapprove all human
research activities overseen or conducted at USU;
(2)
Suspend or terminate approval of human research not being conducted in
accordance with the IRB’s requirements or that has been associated with unexpected
serious harm to participants;
(3)
Observe, or have a third party observe, the consent process;
(4)
Observe, or have a third party observe, the conduct of the research.
(5)
Authorize a separate IRB or other review body that has a current FWA to provide
oversight of a multi-site or specialized study under an authorization agreement, as
allowed by federal statute.
308.4 PROCEDURES

4.1 Principles
Principles that IRB members consider during their reviews are set forth in the IRB Review
Checklist document (available at: http://irb.usu.edu/htm/guidelines) current at the time of
application. These principles include:
(1)
Minimizing the risks to participants.
(2)
Balancing of risks with the potential benefits from the study.
(3)
Obtaining informed consent from the participant or permission from a legal
guardian before participation. Such consent or permission must be in writing unless
waived by the IRB.
(4)
Providing adequate detail about the study in language that is understood by the
participant so the participant can make an informed decision.
(5)
Maintaining participants’ privacy and confidentiality.
(6)
Informing participants that their participation is voluntary and that they are free to
withdraw from the study at any time without consequence.

4.2 Protocols
Protocols submitted to the IRB are categorized as follows:
(1) Exempt from further review
Determination of exempt status shall be made in accordance with the standard operating
procedures of the IRB, and shall in no case be made by an individual who might have a
conflict of interest concerning the study. All research adjudged to be exempt shall
nonetheless be subject to monitoring and continued review by the institution through the
IRB so that the health, well-being and privacy of human participants involved in such
research are adequately protected. Such review shall require an annual update confirming
that the then-current activities qualify for exemption, outlining any changes made in the
protocol or indicating that the project has been completed and/or terminated.
Certain human research shall be exempt from review under the following circumstances,
in accordance with 45 CFR 46.101(b), subsections:
(a)Educational settings (see Decision Charts 2 & 3. All decision charts referred to
in this subsection are available at:
http://www.hhs.gov/ohrp/humansubjects/guidance/decisioncharts.htm).
(b) Or (c) Tests, Surveys, Interviews, Public Behavior Observations (see
Decision Charts 2 & 4).
(d) Existing Data, Documents Records or Specimens (see Decision Charts 2 &
5).
(e) Public Benefit or Service Programs (see Decision Charts 2 & 6).
(f) Food Taste and Acceptance Studies (see Decision Charts 2 & 7).

(2) Subject to expedited review
If the IRB Administrator finds that a protocol involves no more than minimal risk,
expedited review may be conducted by a limited number of experienced board members
who possess expertise in the research activity being conducted. Selection of IRB
members to conduct expedited reviews shall be by the IRB Chair, and expedited reviews
shall be performed in accordance with the standard operating procedures of the USU
IRB. This process generally requires a period of four to six weeks to complete.
(3) Subject to full review
In cases where more than minimal risk is involved, and where expedited review is
deemed by the IRB Administrator to be insufficient or inappropriate, the protocol is
subject to review by the full board. Such reviews typically require a period of four to six
weeks to complete.
4.3 Protocols submitted to the IRB for review
Protocols submitted to the IRB for review shall be presented by a principal investigator,
and shall consist of three components. (Forms and information can be found at
http://www.usu.edu/research/irb)
(1) IRB Application Form
Completion of this form will allow the IRB Administrator to quickly place the protocol in
the appropriate review category (exempt, expedited, or full board review). These forms
have been developed to minimize the response time of the IRB. All sections of the
application must be completed in order for the IRB to begin its review. Information
should be written in lay language, avoiding jargon and acronyms.
(2) Copy of the grant, thesis, or dissertation upon which the project is based
If a project has none of the above documentation, a description of methods and
objectives, and a clear, concise description of procedures to be used in the project shall be
submitted.
(3) Informed Consent Form
This document must conform to the requirements of the IRB standard operating
procedures as reflected in the Informed Consent Checklist (available at:
http://www.usu.edu/research/irb/forms/InformedConsentChecklist.doc) and be approved
for use in the study by the IRB. It contains the following elements as required under 45
CFR 46.116:
(a) A statement that the study involves research
(b) A statement of the research to be performed and the purpose of the research

(c)
(d)
(e)
(f)
(g)
(h)

A description of reasonably foreseeable risks or discomforts
A description of reasonably foreseeable benefits to participants and others
Appropriate alternatives to the study that may benefit the participant
A statement of confidentiality
Availability of compensation or treatment for injury
Contact information for
(i) Answers to pertinent questions about the research
(ii) Answers to pertinent questions about the research participants’ rights
(iii)Reporting of research related injuries or harms
(iv) The research team (if not provided above) for questions, concerns, or
complaints.
(v) Someone independent of the research team for problems, concerns,
questions, information or input

(i) A statement explaining that participation is voluntary and that there is no
penalty or loss of benefit to which the participant was entitled if the
participant withdraws or refuses to participate.
(j) When appropriate:
(i) The consequences of a participant’s decision to withdraw from the
research.
(ii) An approximate number of participants involved in the study.
(k) The informed consent form shall contain adequate information, written in
plain language familiar to the participant, so that he/she can make an informed
decision regarding participation.
4.4 Protocol Process
IRB applications shall be completed on line in accordance with the IRB standard
operating procedures. Incomplete packages will be returned to the investigator without
review. The IRB Administrator and staff work with Investigators to verify completeness
of submissions and identify concerns or needed clarifications. Reviews are then
conducted as described above. If full board review is required, the investigator will
provide ample copies of packets for each board member (as directed by the IRB
administrator) no later than two weeks before the monthly IRB meeting.
Upon completion of the IRB review, notification of decision regarding the protocol is
sent by the IRB Administrator to the investigator. Revisions are sometimes needed, and
when the protocol is considered to meet acceptable standards, the research protocol will
be approved for one year (beginning on the date the protocol was approved), or such
other term (never greater than one year) as shall be determined by the IRB.
For those protocols that require an extension beyond the one-year limitation of the IRB
approval, a status report will be mailed to the investigator by the IRB Office one month

before the anniversary approval date. The investigator will have ten working days from
the date of receipt to submit the Status Report form. A memo shall be attached to the
Status Report form stating the investigator’s intention to continue the research and
document any modification to the experimental protocol. The memo shall contain a
concise overview of the research to date (i.e., current copy of the informed consent,
number of subjects involved, summary of any recent significant findings, adverse events,
etc.). If the protocol is acceptable, an approval letter will be sent to the investigator,
extending the project for an additional year. Continuing review may occur more than
once a year depending on the level of risk.
The investigator will maintain a current file for each protocol he/she submits and have a
copy of all records relating to the research protocol (IRB application form, data derived
from the study/case report forms/computer data/adverse events, correspondence with the
IRB/sponsor/funding sources/FDA/others, sponsor’s protocol—if applicable, original
informed consent and assent forms).
4.5 Retention of Records
Records shall be retained by the PI for all protocols for three years from the date the
study is completed, terminated, or discontinued. Federally-funded research may require a
longer record retention period.
The IRB shall retain for at least three years after the completion of the research (or for
protocols which are cancelled without participant enrollment, for at least a three-year
period after cancellation) the following records in accordance with 45 CFR 45 Section
115:
(1)
Minutes of IRB meetings.
(2)
Protocols
(3)
Scientific evaluations
(4)
DHHS-approved sample consent documents and protocols, when they exist
(5)
Reports of injuries to participants
(6)
Records of continuing review activities including continuing review status reports
submitted to the investigator.
(7)
Other progress reports submitted by investigators.
(8)
Statements of significant new findings provided to participants.
(9)
For initial and continuing review of research by expedited procedure;
(a) The specific permissible category
(b) A description of action taken by the reviewer
(c) Any findings required under regulations
(10) For exemption determinations, the specific category of exemption
(11) Unless documented in the IRB minutes, determinations required by the
regulations and protocol-specific findings supporting those determinations for:
(a) Waiver or alteration of the consent process
(b) Research involving pregnant women, fetuses, and neonates
(c) Research involving prisoners

(d) Research involving children
(12) For each protocol’s initial and continuing review, the frequency for the next
continuing review.
(13) Copies of all correspondence between the IRB and investigators.
(14) A list of IRB members to be maintained on a continuous basis.
(15) The standard operating procedures of the IRB to be maintained on a continuous
basis.
Investigators will notify the IRB office if they either leave the University before the
research is completed, or complete the research and leave the institution before the end of
the three-year record retention date. If the investigator desires to take copies of the
research records to another institution, additional issues may need to be resolved related
to the Health Insurance Portability and Accountability Act (HIPAA, 45 CFR 160).
4.6 IRB Training in the Protection of Human Participants in Research
USU requires Investigators, co-investigators, and any research personnel who interact
with participants in research to be trained in the ethical protection of human participants.
Certification achieved by completion of prescribed training shall be valid for three years
from the date that training was completed.
4.7 Conflicts of Interest
The IRB Application Form shall include questions designed to identify any potential
individual conflicts of interest that may arise in connection with the study. Positive
disclosures of conflicting interests shall be referred by the IRB Administrator to USU’s
Federal Compliance Manager so that the conflict of interest can be fully disclosed and
managed or eliminated, as required under federal guidelines and in accordance with USU
Policy 307 “Conflicts of Interest.” No research for which a conflict of interest has been
disclosed shall be conducted under an IRB-approved protocol until a Conflict of Interest
Management Plan has been approved for the work by the USU Conflict of Interest
Committee. In addition, members of the IRB shall be queried at the beginning of each
IRB review meeting concerning potential conflicts of interest they may have in
connection with protocols to be reviewed. Members of the IRB who disclose such
conflicts may provide information to the Board as requested, but shall recuse themselves
from voting for approval or disapproval of the protocol in question.
4.8 Allegations and Findings of Non-compliance
Non-compliance, for the purposes of this policy, shall be the failure to follow the
regulations or the requirements and determinations of the IRB. Incidents of noncompliance shall be handled by the IRB unless the nature or duration of non-compliance
indicates the need for institutional intervention.
Non-compliant activities may be identified through IRB oversight, self-reporting, or
reporting from employees, human participants or others. Allegations of non-compliance

may be presented to the IRB Administrator, the Federal Compliance Manager at the
OCA, USU’s Internal Audit Services (IAS) either through the hotline or with a
representative of IAS, or to University Counsel. Reports of allegations should be made to
the chair of the IRB, and any report of non-compliant behavior involving research under
the oversight of the IRB shall be reported to the IRB chair at the earliest opportunity.
Sufficient information shall be submitted to identify who exhibited the non-compliant
behavior, when it took place, and any other pertinent details to allow for determination of
non-compliance.
The IRB Chair shall make the initial determination if the allegation is in non-compliance
involving human research. If non-compliance is suspected, but does not involve human
research, the Chair shall provide all pertinent information to the Office of Compliance
Assistance (OCA) for further action.
The IRB Chair shall determine whether non-compliance is serious or continuing. Upon
making a finding of non-compliance that is neither serious nor continuing, the IRB Chair
shall take steps to correct the non-compliant behavior with the investigator. The IRB
Chair shall also notify the department head, dean, the Office of Compliance Assistance,
and the responsible institutional official (RIO) of the circumstances surrounding the
behavior and corrective actions taken.
In cases of serious non-compliance (defined as non-compliant activities that could
jeopardize the rights or safety of human participants) or continuing non-compliance
(defined as non-compliant activities that recur either on the same project or by the same
investigator after the IRB Chair has taken corrective action), the IRB Chair shall notify
the OCA for further action. The OCA has been established to provide support to the IRB,
investigators, human participants, and other individuals and entities with regard to
adherence to federal and state statutes, regulations and guidelines. In conjunction with
USU’s RIO and others, the OCA receives and processes allegations of misconduct and
non-compliance arising from research activities of the University, and facilitates any
associated inquiries and investigations. Information about and contacts for the OCA are
available at: http://www.usu.edu/aia/academic/c_overview.cfm. Following investigation
by the OCA, serious or continuing non-compliance is reviewed by the convened IRB.
The Federal Compliance Manager, an ex-officio member of the IRB, presents the
findings of the investigation. All members of the RIB receive a copy of the initial
application, the protocol, information describing the non-compliance, and the results of
the OCA investigation. The IRB may consider actions including
(1)
Suspension of the research
(2)
Termination of the research and notification of current participants when such
information may relate to a participant’s willingness to continue to take part in the
research
(3)
Increasing frequency of continuing review
4.9 Unanticipated Problems

Investigators shall follow the procedures contained in the IRB standard operating
procedures, Chapter 9.j whenever an unanticipated problem arises having to do with risks
to human participants or others. The PI shall have responsibility for identifying and
reporting unanticipated risks as set forth in the SOPs, Chapter 4.f, submitting information
to the chair of the IRB in sufficient detail for the Chair to draft the report as required in
4.11, below, and otherwise as required by the SOPs. If the unanticipated risk is lifethreatening, emergency services shall be summoned and all reasonable steps shall be
taken to ensure the safety and well-being of the participants or any others affected.
4.10 Suspensions and Terminations of Previously Approved Research
The IRB is authorized to suspend (defined as temporarily discontinuing) or terminate
(defined as permanently discontinuing) research in order to protect the rights and welfare
of research participants and others.
The determination of the appropriate action shall be made by the IRB chair, based on
non-compliance with the IRB-approved protocol for the research, or on the association of
the research with an unexpected serious harm to participants or others. Determinations
shall be ratified by the membership of the IRB, and shall be reported to the OCA, RIO,
University Counsel, and the appropriate funding agency as set forth in 4.11, below.
Suspensions may be lifted if an investigation determines that the harm was not associated
with the research, or if compliance with the approved protocol is re-established, and is
determined to be sufficient to protect the rights and welfare of human participants.
When a termination or suspension involves the withdrawal of current participants from a
study:
(1)
Enrolled participants will be notified by the IRB.
(2)
Participants to be withdrawn will be informed by the IRB of any unexpected risks
to which they may have been subjected, and shall be provided with support in
understanding and ameliorating those risks.
(3)
Participants to be withdrawn will be informed by the IRB of any follow-up that is
required or offered, and will be informed that any adverse event or unanticipated
problems involving risks to them or others should be reported to the IRB and others as
appropriate.
4.11 Reports of Unanticipated Problems
Reports of unanticipated problems involving risks to participants or others, terminations,
suspensions and serious or continuing non-compliance shall be submitted to federal
agencies in compliance with applicable regulations. The IO shall ensure that all required
reportings are completed within 15 business days.

The IRB Chair shall have responsibility for coordinating with the principal investigator,
gathering any additional required information and writing the initial report, which shall
include:
(1)
(2)
(3)
(4)
(5)

The nature of the event or problem
The findings of USU
The action taken by the IRB and USU
The reasoning underlying the actions taken
Any plans or recommendations for a continuing inquiry or investigation

The IRB chair shall submit the draft report in a timely manner to the OCA and the RIO
for review. The RIO shall have responsibility for final approval and signature of the
report, and for its submission to the appropriate agency. Copies of the reports shall be
distributed to the IRB, OHRP when the research is covered by DHHS regulations, and
other federal agencies when research is overseen by those agencies and such agencies
required reporting separate from that to OHRP.
308.5 CONTINUOUS IMPROVEMENT OF THE HUMAN RESEARCH
PROTECTION PROGRAM
The IRB and OCA shall work together to measure and report the performance of the
Human Research Protection Program to USU’s administration. Annual and unannounced
reviews of the IRB’s operating and review procedures shall be carried out in order to
assess the effectiveness and quality of the processes; and to assure compliance with
USU’s policies and procedures, and with applicable federal, state and local laws and
guidelines.
USU Investigators, other USU employees, human participants and sponsors of research
are encouraged to bring forward concerns and suggestions regarding improvement of the
program, including the IRB review process.
308.6 RECRUITMENT PROHIBITIONS
The following activities shall not be permitted:
(1)
Payments to professionals in exchange for referrals of potential participants
(finder’s fees).
(2)
Payments designed to accelerate recruitment that are tied to the rate of timing of
enrollment (bonus payments).
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Report from the Educational Policies Committee
March 5, 2009
The Educational Policies Committee met on March 5, 2009. The agenda and minutes of the meeting are
posted on the Educational Policies Committee web page1 and are available for review by the members of
the Faculty Senate and other interested parties.
During the March 5th meeting of the Educational Policies Committee, the following discussions were held
and key actions were taken.
1. Approval of the report from the Curriculum Subcommittee which included the following notable
actions (Curriculum Subcommittee minutes2):
•

The Curriculum Subcommittee approved 44 requests for course actions (see minutes2).

•

The request from the Department of Mechanical and Aerospace Engineering to offer a
Master of Science graduate degree in Aerospace Engineering was approved.

•

The request from the Department of Economics and Finance to offer a Minor in Quantitative
Finance was approved.

2. There was no February meeting of the Academic Standards Subcommittee to report on.

3. Approval of the report of the February General Education Subcommittee. Of note:
•

The General Education Subcommittee is evaluating five year student performance data
on the Computer Information Literacy (CIL) Exam in preparation for a discussion on the
disposition of the CIL at their March meeting.

•

In response to a request by the Commissioner’s Office of Higher Education to consider
the AAC & U Liberal Education and America’s Promise (LEAP) Essential Learning
Outcomes, it was agreed that Utah State University’s Citizen Scholar Objectives were
consistent with the LEAP objectives. However, two modifications were made to USU’s
Citizen Scholar Objectives:
3. recognize different ways of thinking, creating, expressing, and communicating
through a variety of media including: written, oral, visual, musical, and kinesthetic
communication;
5. ethical reasoning including the ability to work effectively and responsively, both
collaboratively and individually, in all facets of their lives.

1.

http://www.usu.edu/fsenate/EPC/2008-2009/Minutes/Mar52009epcminutes.pdf

2.

http://www.usu.edu/fsenate/EPC/curriculum/2008-2009/Minutes/Mar52009ccminutes.pdf

REPORT OF THE
HONORARY DEGREE AND AWARDS COMMITTEE
to the
Faculty Senate
April 6, 2009
The information contained in this document is CONFIDENTIAL and for review by the Faculty Senate only.
It is not to be disseminated to any person outside of the Faculty Senate.

COMMITTEE MEMBERS
Paul D. Parkinson, Chair (Board of Trustees and Alumni Council President)
Scott R. Watterson (Board of Trustees)
Suzanne Pierce-Moore (Board of Trustees)
Scott Deberard (Faculty)
Douglas Jackson-Smith (Faculty)
Wayne Wurtsbaugh (Faculty)
MerLynn Pitcher (Alumni Council)
Grady Brimley (ASUSU President)
Laurens Smith (Provost’s Office)
Sydney Peterson (President’s Office)
PURPOSE
The Honorary Degrees and Awards Screening Committee’s major responsibilities are to implement
procedures to solicit and encourage an adequate number of qualified nominations; to review all
nominations for Honorary Degrees and Commencement Speaker Awards; and to forward nominations
and recommendations to the Board of Trustees for their final selection and approval.
COMMITTEE ACTIONS
Honorary Degree Recipients 2009
The Honorary Degree and Awards Screening Committee recommended five candidates for honorary
degrees to be presented at Spring Commencement 2009. The Board of Trustees has approved the
following five candidates:
Robert F. Bennett
Reelected to a third term in the United States Senate in 2004, Senator Bob Bennett continues to serve
the citizens of Utah with distinction. As counsel to Republican Leader Mitch McConnell, Senator Bennett
retains his seat on the Republican leadership team where he advises the leader on legislative strategy
and policy priorities. As a senior member of the Senate Banking Committee, and a member of the
distinguished Joint Economic Committee, the Utah Senator is at the center of national economic policy
discussions. From his seat on the powerful Senate Appropriations Committee, where he is the ranking
member of the Subcommittee on Agriculture, Bennett works to balance fiscal discipline in government
while also representing the needs of Utah in the distribution of federal funds. The Utah Republican also
serves as the ranking Republican member on the Senate Rules Committee. Named an “Emerging
Leader in a Post-September 11 Senate” by Congressional Quarterly Magazine, Bennett has received
numerous awards for his contributions in the U.S. Senate. Prior to his election to the Senate in 1992,
Bennett earned distinction in entrepreneurial and government activities. For his success as chief
executive officer of the Franklin International Institute Bennett was named Inc. Magazine’s “Entrepreneur
of the Year” for the Rocky Mountain region. His Washington, D.C., experience includes service as chief
congressional liaison at the U.S. Department of Transportation.

Marc C. Bingham
Marc Bingham is a graduate of Utah State University with a degree in wildlife management. In 1971 he
founded and became the chief executive officer of PDC (Phone Directories Company), one of the most
successful independent publishers in the yellow page industry. Prior to beginning PDC, he worked for the
Bureau of Land Management in Price. Marc and his wife, Debbie, donated $15 million to Utah State
University’s Uintah Basin campus to fund construction of an Entrepreneurship and Energy Research
Center. The gift is the largest private gift in USU’s history. The building will become a state-of-the-art,
high-tech educational facility to train students in business, entrepreneurship, accounting, engineering,
water management, natural resources, environmental policy and other programs. The new
Entrepreneurship and Energy Research Center will help Utah, the region and the nation develop energy
resources more efficiently by enabling teams of professionals from key disciplines to work together with
government, business and community partners to create synergistic solutions and to foster
entrepreneurship.
Huey D. Johnson
Huey Johnson, a 1966 Utah State University graduate in Natural Resources, is an environmentalist and
practical visionary, widely recognized for his pioneering work as a conservationist and environmental
policymaker. He is the founder and president of the Resource Renewal Institute (RRI), an incubator for
transformational ideas that challenge the piecemeal way natural resources are managed in favor of longterm, comprehensive policies that will guarantee the health of the planet and a high quality of life for
future generations. He is a leading voice for Green Plans, integrated environmental strategies that are a
proven and effective approach to protecting and sustaining the environment. Mr. Johnson served as
president of The Nature Conservancy, and was its Western Regional Director for nine years. From 1976
until 1982, Mr. Johnson served as Secretary of Resources for the State of California. During his tenure
he established conservation programs that doubled salmon populations, strengthened forestry
regulations, preserved millions of acres of California wilderness, and protected more than 1,200 miles of
wild rivers. Mr. Johnson is active in environmental affairs worldwide, serving on boards, advising political
leaders, writing, and lecturing. He is the author of Green Plans: Greenprint for Sustainability (University
of Nebraska Press, 1995). The book, now in its third printing, is part of environmental planning curricula
at a number of universities. Mr. Johnson has received numerous awards including the President’s Award
for Sustainable Development in 1996 and the Sasakawa Prize, awarded by the United Ntaions in 2001 to
honor Mr. Johnson’s outstanding contributions to the environment.
Bonnie D. Parkin
Bonnie Parkin was the fourteenth general president of the Relief Society of The Church of Jesus Christ of
Latter-day Saints (LDS Church) from 2002 to 2007. Parkin was also a member of the general presidency
of the church’s Young Women organization from 1994 to 1997. She graduated from Utah State
University in 1962. As general Relief Society president not only did she represent over 5 million LDS
women in 165 countries, but she reached out to literally thousands of non-LDS women and families.
Examples of this include her partnership with organizations such as the United Nations, the World Health
Organization and the American Red Cross to vaccinate children against measles in Mozambique and
Ethiopia, her efforts to help those devastated by Hurricane Katrina, and her program to teach a group of
Iraqi women how to care for and serve each other. She has focused much of her energy on preparing
and nurturing young women. Her efforts to help women and serve families in need have taken her
throughout the world, from South America to Asia, Europe and Africa.
Bertrand D. Tanner
Bertrand Tanner received his M.S. in Biometeorology from USU in 1975. He joined Campbell Scientific
Inc., and rose to a position of Vice President. This company is internationally known for measurement
systems used widely in environmental sciences, industry, and agriculture. He has been personally
responsible for developing some unique sensors and measurement systems which are now indispensible
in many areas of science, environmental monitoring and advanced agricultural technology. Areas which

use this technology include: monitoring the carbon budget of the Earth; studies and monitoring of air
quality; determining efficient water use and pest control in agriculture; monitoring water quality, climate
science and climate change. Mr. Tanner is a rare individual who not only rose to distinction in his
profession, but also surpassed the academic standards defining a traditional doctorate degree.
Mr. Tanner was diagnosed with cancer in late May 2008, and passed away in September 2008, much
faster than expected. The process of nominating him for an honorary degree began well before this
occurred. He will receive the award posthumously.
Commencement Speaker 2009
The Board of Trustees has approved Senator Robert F. Bennett as the Commencement Speaker for
Spring 2009 (see short bio above). Additional names have been submitted for Commencement Speaker
for Spring 2010.

